Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Internal validation & live display
Insurers and partners see a safer profile
Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Society of ActuariesCAS
Proud contributor to the Society of Actuaries.
Company Logo
JDC
Boost Score +25 with badge (5 left)
706
/1000
Moderate
Verified Badge
Boost Arrows
731
/1000
Moderate
Joslin Diabetes Center

Joslin Diabetes Center Vendor Cyber Rating & Cyber Score

joslin.org

Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. Joslin is dedicated to finding a cure for diabetes and ensuring that people with diabetes live long, healthy lives. We develop and disseminate innovative patient therapies and scientific discoveries throughout the world. Joslin is an independent, non-profit institution affiliated with Harvard Medical School, and one of only 11 NIH-designated Diabetes Research Centers in the U.S. OUR VISION: A world free of diabetes and its complications OUR MISSION: To prevent, treat and cure diabetes.


JDC A.I CyberSecurity Scoring

Scoring History
JDC
Company Information
Website:http://www.joslin.org
Employees number:599
Number of followers:12,106
NAICS:62
Industry Type:Hospitals and Health Care
Homepage:joslin.org
JDC Risk Score (AI oriented)
Between 700 and 749
logo
JDCHospitals and Health Care
Updated:
04/04/2026
706/1000
Moderate
Ba
AaaAaABaaBaBCaaCaC
Powered by our proprietary A.I cyber incident model
Insurance prefers TPRM score to calculate premium
JDC Global Score (TPRM)
xxxx
logo
JDCHospitals and Health Care
•••
Score locked
Instant access to detailed risk factors
Vulnerabilities
Benchmark vs. industry & size peers
Findings
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…